Profile
BBLG ABT BSX-PA SYK BSX MDT
Company Name Bone Biologics Corporation Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $3.84M $231.06B $175.45B $150.29B $146.66B $120.82B
Employees 0.00K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Jeffrey Frelick Robert B. Ford Michael F. Mahoney Kevin A. Lobo Michael F. Mahoney Geoffrey Straub Martha
Ratings
BBLG ABT BSX-PA SYK BSX MDT
Quant Rating Score 2 4 3 3 3
Quant Rating Sell Buy Neutral Neutral Neutral
Trading
BBLG ABT BSX-PA SYK BSX MDT
Last Close $2.14 $132.76 $122.18 $376.62 $98.98 $94.19
High 52 $6.2 $140.22 $122.18 $403.53 $108.14 $94.5
Low 52 $0.66 $111.1 $122.18 $337.28 $82.52 $79.61
Price vs. 52 Week High -65.48 % -5.32 % 0 % -6.67 % -8.47 % -0.33 %
Price vs. 52 Week Low 224.24 % 19.5 % 0 % 11.66 % 19.95 % 18.31 %
Total Return
BBLG ABT BSX-PA SYK BSX MDT
1 Month Return -2.73 % 0.77 % 0 % -1.39 % -4.06 % 1.26 %
3 Month Return -57.87 % 0.36 % 0 % 0.89 % -2.7 % 9.31 %
6 Month Return 157.09 % 4.01 % 0 % 0.89 % 0.08 % 0.9 %
9 Month Return 103.81 % 17.19 % 0 % 1.57 % 9.45 % 15.76 %
YTD Return 127.59 % 17.37 % 0 % 4.6 % 10.82 % 17.91 %
1 Year Return 23.7 % 12.38 % 0 % 3.48 % 19.95 % 6.27 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BBLG ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 1.75 % - 0.84 % - 2.98 %
Dividend Paid and Capex Coverage Ration (TTM) -0.52 % 1.45 % 4.3 % 2.39 % 4.3 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - 3.32 % - 2.81 %
Payout Ratio (TTM) -152.23 % 28.42 % 0.92 % 42.87 % 0.92 % 77.26 %
Growth
BBLG ABT BSX-PA SYK BSX MDT
Asset Growth 3.31 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth - 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth - 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year - -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year - 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year - 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth 54.05 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth 54.05 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 92.76 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share 95.96 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 99.97 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth 55.25 % 6.46 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 56.83 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG 90.48 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG 95.73 % 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG 99.96 % 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth 85.8 % 134.55 % 16.55 % 16.55 % 31.05 %
EPS Diluted Growth 85.8 % 133.64 % 16.25 % 16.25 % 30.8 %
Book Value Per Share -79.21 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -98.5 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 100.99 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 100.03 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth - -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth 56.83 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
BBLG ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM - 52.79 % 63.23 % 62.19 % 63.23 % 63.44 %
Return on Assets TTM -60.27 % 16.64 % 6.02 % 6.3 % 6.02 % 5.12 %
Return on Equity TTM -100.59 % 29.93 % 11.49 % 14.08 % 11.49 % 9.62 %
Return on Capital Employed TTM -65.07 % 10.7 % 8.53 % 13.86 % 8.53 % 7.71 %
Net Income Per EBT TTM 100 % 176.99 % 83.43 % 87.08 % 83.43 % 82.32 %
EBT Per Ebit TTM 98.33 % 104.64 % 96.68 % 61.93 % 96.68 % 92.49 %
EBIT Per Revenue TTM - 17.51 % 16.77 % 22.72 % 16.77 % 17.9 %
Cash Flow To Debt Ratio TTM - 67.25 % 35.63 % 27.83 % 35.63 % 24.98 %
Receivables Turnover TTM - 4.21 6.57 6.08 6.57 5.46
Payables Turnover TTM - 4.73 7.07 6.25 7.07 4.89
Inventory Turnover TTM - 2.93 2.38 1.7 2.38 -33.52
Fixed Asset Turnover TTM - 378.32 % 467.97 % 560.03 % 467.97 % -6785.71 %
Asset Turnover TTM - 51.32 % 44.5 % 51.41 % 44.5 % 37.59 %
Operating Cash Flow Per Share TTM -5.94 5.19 2.9 12.47 2.9 5.58
Free Cash Flow Per Share TTM -5.94 3.89 2.24 10.53 2.24 4.14
Cash Per Share TTM 1190.5 % 418.4 % 36.12 % 644.69 % 36.12 % 633.66 %
Operating Cash Flow Sales Ratio TTM - 20.96 % 23.17 % 20.01 % 23.17 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 74.97 % 77.27 % 84.43 % 77.27 % 74.21 %
Cash Flow Coverage Ratios TTM - 67.25 % 35.63 % 27.83 % 35.63 % 24.98 %
Price To Free Cash Flows Ratio TTM -1.16 34.11 44.3 37.35 44.3 22.78
Price To Operating Cash Flows Ratio TTM -0.36 25.57 34.15 31.52 34.15 16.89
Price Cash Flow Ratio TTM -0.36 25.57 34.15 31.52 34.15 16.89
Income Statement (TTM)
BBLG ABT BSX-PA SYK BSX MDT
Revenue $0B $41.95B $16.75B $22.6B $16.75B $33.54B
Gross Profit $0B $21.33B $10.27B $13.98B $10.27B $21.91B
Gross Profit Ratio 0% 50.83% 61.31% 61.87% 61.31% 65.32%
EBITDA $-0B $10.83B $3.94B $4.94B $3.94B $9.22B
Net Income $-0B $13.4B $1.85B $2.99B $1.85B $4.66B
EPS Diluted -4.83 7.64 1.25 7.76 1.25 3.61
Balance Sheet (MRQ)
BBLG ABT BSX-PA SYK BSX MDT
Long Term Debt $0B $13.52B $9.37B $12.57B $9.37B $25.64B
Total Liabilities $0B $33.51B $17.39B $22.34B $17.39B $43.42B
Total Equity $0B $47.9B $22B $20.63B $22B $48.26B
Total Investments $0B $1.24B $0.56B $0.88B $0.56B $6.75B
Total Debt $0B $15.28B $11.15B $14.12B $11.15B $28.52B
Total Assets $0B $81.41B $39.4B $42.97B $39.4B $91.68B
Cash Flow Statement (TTM)
BBLG ABT BSX-PA SYK BSX MDT
Net Income $-0B $13.4B $1.85B $2.99B $1.85B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.21B $-0.23B $-0.29B
Dividends Paid $-0B $-3.84B $0B $-1.22B $0B $-3.59B
Operating Cash Flow $-0B $8.56B $3.44B $4.24B $3.44B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-0.79B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 134.14
ADGM Adagio Medical Holdings, Inc. 1.62
AEMD Aethlon Medical, Inc. 0.7471
AFIB Acutus Medical, Inc. 0.0011
AHCO AdaptHealth Corp. 8.92
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 129.44
ALUR Allurion Technologies Inc. 2.12
AMIX Autonomix Medical, Inc. Common Stock 1.14
ANIK Anika Therapeutics, Inc. 8.65
AORT Artivion, Inc. 39.92
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.24
ARAY Accuray Incorporated 1.595
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 14.705
AVNS Avanos Medical, Inc. 11.86
AVR Anteris Technologies Global Corp. Common Stock 5.59
AXDX Accelerate Diagnostics, Inc. 0.034
Unlock